Previous Article | Next Article ![]()
Journal of Clinical Microbiology, July 2005, p. 3297-3303, Vol. 43, No. 7
0095-1137/05/$08.00+0 doi:10.1128/JCM.43.7.3297-3303.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Sibylle Stindl,2,
Wolfgang Ludwig,2
Anita Stumpf,1
Andre Mehlen,2
Daniel Monget,3
Denis Pierard,4
Stefan Ziesing,5
Jürgen Heesemann,6
Andreas Roggenkamp,6 and
Karl H. Schleifer2
Institute of Microbiology and Laboratory Medicine at the Pneumological Teaching Hospital of the University of Munich, Robert-Koch-Allee 2, D-82131 Gauting, Germany,1 Lehrstuhl für Mikrobiologie, Technische Universität München, D-85353 Freising, Germany,2 BioMérieux, R&D Microbiology, Marcy l'Etoile, France,3 Academisch Ziekenhuis Vrije Universiteit van Brussel, 1090 Brussels, Belgium,4 Institute of Microbiology, Medizinische Hochschule, Hannover, Germany,5 Max von Pettenkofer Institute for Hygiene and Medical Microbiology, Ludwig Maximilian University Munich, Klinikum Grosshadern, Marchioninistrasse 17, D-81377 Munich, Germany6
Received 3 August 2004/ Returned for modification 30 September 2004/ Accepted 2 March 2005
|
|
|---|
Tm values, ranging from 0.3 to 4.8, confirming the hypothesis that the clusters are parts of the same species. These clusters can be distinguished from the other species of the E. cloacae complex, which have
Tm values of 5.6 to 10.3. Forty-eight E. hormaechei strains from the different genetic clusters were phenotypically characterized with 129 biochemical tests. In this way, E. hormaechei could be differentiated from the other species of the E. cloacae complex because it tests negative in the 3-hydroxy-butyrate test. The three genetic clusters of E. hormaechei could also be differentiated from each other by using phenotypic tests. Hence, we propose three new subspecies of E. hormaechei corresponding to genetic clusters VI, VII, and VIII of the E. cloacae complex. E. hormaechei subsp. hormaechei comb. nov. corresponds to the original species description, as it gives negative results for the adonitol, D-arabitol, D-sorbitol, and D-melibiose tests and a positive result for the dulcitol test. E. hormaechei subsp. oharae subsp. nov. gives negative results for the dulcitol, adonitol, and D-arabitol tests and positive results for the D-sorbitol and D-melibiose tests. E. hormaechei subsp. steigerwaltii subsp. nov. gives a negative result for the dulcitol test and positive results for the adonitol, D-arabitol, D-sorbitol, and D-melibiose tests. Among the members of the E. cloacae complex, E. hormaechei seems to be the species most frequently recovered from clinical specimens. |
|
|---|
E. hormaechei was first described on the basis of 23 isolates sent to the Centers for Disease Control and Prevention (Atlanta, Ga.) for identification. At that time, they could not be assigned to a species, since they were negative in D-sorbitol and melibiose tests and did not fit the biochemical profile of any established Enterobacter species. Later, this preselected set of isolates turned out to be genetically closely related to each other. The species E. hormaechei was proposed to be lactose, D-sorbitol, raffinose, melibiose, and esculin negative and 87% dulcitol positive (12). Subsequently, a clinical outbreak was observed that was caused by a different biotype of E. hormaechei, challenging the original species description (4). In a hybridization study of clinical isolates of the E. cloacae complex performed by Grimont and Grimont (6), E. hormaechei represented the most prominent proportion of all isolates studied (33%). Similarly, the E. hormaechei metacluster comprised 44% of all strains in our recent population genetic study (7). Because of its apparently highly underestimated clinical relevance (6, 7), we studied the E. hormaechei metacluster further, concluding that it consists of three different subspecies, for which we propose the names E. hormaechei subsp. oharae, E. hormaechei subsp. hormaechei, and E. hormaechei subsp. steigerwaltii.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Strains used for this study
|
KH2PO4, 0.5% Na2HPO4 · H2O) at pH 7.6 containing 75
KCN. Arginine dihydrolase and ornithine decarboxylase activities were tested in Moeller's broth (pH 6.5), consisting of 0.5% peptone, 0.5% meat extract, 0.05% glucose, 0.5% pyridoxal, bromcresol purple, cresol red, and 1% respective amino acids (2). The esculin hydrolase test was performed with a broth containing 0.3% NaCl, 0.2% K2HP4, 0.3% Lab-Lemco medium, 1% peptone, and 0.1% esculin (2). Citrate activity was tested on Simmon's agar (Oxoid, Basingstoke, Hampshire, United Kingdom). The Voges-Proskauer test was performed according to the guidelines given by Chapin and Lauderdale (3). Urease activity was tested in a broth (pH 7.1) consisting of 0.5% NaCl, 0.2% KH2PO4, 0.1% glucose, 0.1% peptone, phenol red, and 2% urea (2). Additionally, urease activity was tested on Christensen's agar. Antimicrobial susceptibilities to ampicillin, amoxicillin plus clavulanic acid, piperacillin, piperacillin plus tazobactam, cefoxitin, ceftazidime, cefotaxime, cefepime, meropenem, ciprofloxacin, gentamicin, and trimethoprim plus sulfamethoxazole were determined by disk diffusion tests on Mueller-Hinton agar on the basis of the quantitative interpretation criteria recommended by the Clinical and Laboratory Standards Institute (11). All phenotypic and susceptibility tests were performed at 37°C in ambient air. DNA preparations and DNA-DNA hybridizations in microplates were performed as described by Mehlen et al. (10).
Nucleotide sequence accession numbers. Nucleotide sequence data are available at the EMBL/GenBank/DDBJ database under accession numbers AJ853889 and AJ853890 for 16S rRNA genes and under accession numbers AJ417108, AJ417124, AJ417129, AJ417141, AJ417142, AJ417143, AJ543761, AJ543765, AJ543766, AJ543771, AJ543777, AJ543779, AJ543782, AJ543783, AJ543788, AJ543790, AJ543791, AJ543795, AJ543796, AJ543798, AJ543810, AJ543811, AJ543815, AJ543821, AJ543822, AJ543825, AJ543826, AJ543827, AJ543835, AJ543836, AJ543846, AJ543849, AJ543851, AJ543854, AJ543863, AJ543908, AJ567895, AJ567899, AJ567900, AJ862841, AJ862866, and AJ862867 for hsp60 genes.
|
|
|---|
Tm values resulting from the hybridizations are presented in Table 2. The close DNA-DNA relatedness within clusters VI and VII was reflected by
Tm values below 0.5. The relatively higher heterogeneity of cluster VIII was indicated by higher within-group
Tm values of up to 2.7. By evaluating the DNA relatedness among the clusters, we found that clusters VI and VIII are closely related (mean
Tm value = 2.2), while a relatively longer distance for E. hormaechei cluster VII from the members of clusters VI and VIII was indicated by the mean
Tm value of 4.0. However, all three genetic clusters could still be assigned to the same species (14). They could be genetically distinguished from the other species of the E. cloacae complex, which had
Tm values of 5.6 to 10.3 (Table 2). Phenotypic characterizations allowed a clear distinction of the E. hormaechei metacluster from the rest of the E. cloacae complex, e.g., by the lack of growth on 3-hydroxy-butyrate (Table 3). Similar to the original species description, the six E. hormaechei strains of cluster VII were negative in the esculin (0%), D-sorbitol (17%), and
-D-melibiose (17%) tests and positive in the dulcitol test (100%). However, some strains grew on raffinose (50%) and lactose (67%), which was inconsistent with the results of the study set used for the original species description, as none of those strains were raffinose positive and only 9% were lactose positive. Genetic clusters VI, VII, and VIII were differentiable from each other by their growth on dulcitol and adonitol and by other test results (Table 3). |
View this table: [in a new window] |
TABLE 2. DNA relatedness of representatives of the species and subspecies of the E. cloacae complex
|
|
View this table: [in a new window] |
TABLE 3. Biochemical reactions of 48 strains in the API20E system, the Biotype 100 system, and conventional testsa
|
Tm values ranging from 0.0 to 4.0." The authors observed seven biogroups within the DNA-relatedness group. Two of them were positive for growth on adonitol, D-arabitol, and D-sorbitol, corresponding to phylogenetic cluster VIII. Four were negative for growth on adonitol and D-arabitol but positive for growth on D-sorbitol, corresponding to phylogenetic cluster VI, and one was negative in all three tests, corresponding to E. hormaechei cluster VII. Davin-Regli et al. (4) reported an outbreak with an "E. cloacae strain with the E. hormaechei genotype" but an aberrant biotype. The strain exhibited all of the characteristics of E. hormaechei and was 80% related to the type strain in DNA-DNA reassociation experiments but was positive for growth on D-sorbitol and
-D-melibiose. Obviously, this outbreak was caused by a strain of genetic cluster VI. Hence, these studies are in agreement with our observation that genetic clusters VI and VIII belong to the species E. hormaechei (4, 6). Therefore, we propose that these clusters are new subspecies of E. hormaechei and we consequently reassign the species itself to E. hormaechei subsp. hormaechei comb. nov., which more or less keeps the original characteristics of the species. Emended description of Enterobacter hormaechei O'Hara et al. 1989. Enterobacter hormaechei (hor.maé'che.i. N.L. gen. m. Hormaeche, after Estenio Hormaeche, a Uruguayan microbiologist, who, together with P. D. Edwards, proposed and defined the genus Enterobacter [9]).
This emended description is based on phylogenetic sequence data and DNA-DNA hybridization data collected from 48 strains during the course of the present study and a previous population genetic study (7). Phenotypic characterization was performed by using the API20E and Biotype 100 systems and a series of conventional tests performed during the course of the present study. E. hormaechei strains are gram-negative rods which are 83% motile, catalase positive, oxidase and DNase negative, fermentative, and nonpigmented and exhibit the general characteristics of the family Enterobacteriaceae, the genus Enterobacter, and the E. cloacae complex. Growth occurs as nonpigmented colonies after 18 to 24 h at 15 to 42°C, with an optimum at 36°C, on all nonselective media, such as Colombia agar with 5% sheep blood, chocolate agar, tryptic soy agar, Luria-Bertani agar, and brain heart infusion agar, as well as on semiselective media such as MacConkey and ENDO agar. A detailed biochemical profiling of the species is given in Table 3. Growth on the following substances is subspecies specific: D-sorbitol, D-fucose,
-D-melibiose, 1-0-methyl-
-galactopyranoside, D-arabitol, dulcitol, D-(+)-raffinose, adonitol, and 3-methyl-D-glucopyranose. Table 4 shows the tests used for the differentiation of E. hormaechei and its subspecies from the other species of the genus. The G+C content of the DNA is 58.3 ± 0.3 mol% (Tm).
|
View this table: [in a new window] |
TABLE 4. Biochemical differentiation of E. hormaechei subspecies from other clinically relevant species of the E. cloacae complex
|
Description of Enterobacter hormaechei subsp. hormaechei comb. nov (12). The description of Enterobacter hormaechei subsp. hormaechei comb. nov is based on the particular properties given in Table 3. E. hormaechei subsp. hormaechei corresponds to genetic cluster VII of the population structure of the E. cloacae complex which was presented recently (7). The biochemical tests used for the differentiation of this subspecies from the other E. hormaechei subspecies and from other Enterobacter species are subsumed in Table 4. All strains produced a Bush class 1 beta-lactamase at a low level, conferring resistance to ampicillin, amoxicillin plus clavulanic acid, and cefoxitin, but not to cefotaxime, ceftazidime, and cefepime, in agar diffusion tests. All strains were susceptible to meropenem, ciprofloxacin, trimethoprim plus sulfamethoxazole, and gentamicin.
The type strain, ATCC 49162 (equivalent to CIP 103441T and CCUG 27126T), was isolated from the sputum of a male patient from California (12).
Description of Enterobacter hormaechei subsp. oharae subsp. nov. E. hormaechei subsp. oharae (o.há'rae. N.L. gen. f. Ohara, in honor of Caroline M. O'Hara, an American microbiologist who is affiliated at this time with the Centers for Disease Control, Atlanta, Ga., and who originally described the species E. hormaechei [12] and has contributed greatly to the taxonomy of various Enterobacteriaceae).
This description is based on the particular properties given in Table 3. E. hormaechei subsp. oharae corresponds to genetic cluster VI of the population structure of the E. cloacae complex which was presented recently (7). The biochemical tests used for the differentiation of this subspecies from the other E. hormaechei subspecies and from other Enterobacter species are subsumed in Table 4. All strains produced a Bush class 1 beta-lactamase (AmpC), with 69% producing the enzyme at a low level, conferring resistance to ampicillin, amoxicillin plus clavulanic acid, and cefoxitin, but not to cefotaxime, ceftazidime, and cefepime, in agar diffusion tests. Twenty-five percent of the strains hyperproduced the AmpC protein, conferring additional resistance to piperacillin, piperacillin plus tazobactam, cefotaxime, and ceftazidime, but not to cefepime, gentamicin, and trimethoprim plus sulfamethoxazole. One strain (EN-312) produced an extended-spectrum beta-lactamase and was resistant to all beta-lactam antibiotics, cephalosporins, and trimethoprim plus sulfamethoxazole. All strains were susceptible to meropenem and ciprofloxacin.
The type strain is EN-314, which is available at the German Collection of Microorganisms and Cell Cultures (DSMZ 16687T) and the Collection de l'Institut Pasteur (CIP 108490T). It was isolated from a mouth swab of a 2-year-old infant. The GenBank accession number for its 16S rRNA gene sequence is AJ853889.
Description of Enterobacter hormaechei subsp. steigerwaltii subsp. nov. E. hormaechei subsp. steigerwaltii (stei.ger.wál'ti.i. N.L. gen. m. Steigerwalt, in honor of Arnold G. Steigerwalt, an American microbiologist who contributed to the species descriptions of E. asburiae and E. hormaechei).
This description is based on the particular properties given in Table 3. E. hormaechei subsp. steigerwaltii corresponds to genetic cluster VIII of the population structure of the E. cloacae complex which was presented recently (7). The biochemical tests used for the differentiation of this subspecies from the other E. hormaechei subspecies and from other species of the E. cloacae complex are subsumed in Table 4. All strains produced a Bush class 1 beta-lactamase (AmpC), with 54% producing the enzyme at a low level, conferring resistance to ampicillin, amoxicillin plus clavulanic acid, and cefoxitin, but not to the rest of the antibiotics tested. Forty-two percent of the strains hyperproduced the AmpC protein, conferring additional resistance to piperacillin, piperacillin plus tazobactam, cefotaxime, and ceftazidime, but not to cefepime, gentamicin, and trimethoprim plus sulfamethoxazole. One strain (EN-331) produced an extended-spectrum beta-lactamase and was resistant to all beta-lactam antibiotics, cephalosporins, and trimethoprim plus sulfamethoxazole. All strains were susceptible to meropenem and ciprofloxacin.
The type strain is EN-562, which is available at the German Type Cell Collection (DSMZ 16691T) and the Collection de l'Institut Pasteur (CIP 108489T). It was recovered from an infected surgical skin wound of a 49-year-old patient with tonsillar carcinoma. The GenBank accession number for its 16S rRNA gene sequence is AJ853890.
We particularly thank Mrs. Kleinhuber and ESCMID for the publication of our "call for strains." Many thanks go to all colleagues who collected and sent strains for this study, i.e., S. Alberti, Palma de Mallorca, Spain, J. Bille, Lausanne, Switzerland, D. Bitter-Suermann, Hannover, Germany, A. Dierkes-Kersting and P. Breuer, Gelsenkirchen, Germany, H. Erichsen, Kiel, Germany, S. Lukas, Regensburg, Germany, C. E. Nord, Stockholm, Sweden, W. Pfister, Jena, Germany, K. Poschinger, Munich, Germany, V. Schäfer, Frankfurt, Germany, R. Smyth, Växjö, Sweden, M. Stark and I. Authenrieth, Tübingen, Germany, J. Wagner, Berlin, Germany, and A. Wenger, Lausanne, Switzerland, and to all other colleagues who provided us with strains.
H.H. and S.S. contributed equally to this study. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»